Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: September 29, 2025
In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels as…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 26, 2025
In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of Eli Li…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 25, 2025
In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial setba…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 24, 2025
In today’s Pharmaceutical Executive Daily, we cover the market reaction to Trump’s Tylenol–autism claim, the FDA’s complete response letter to Schola…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 23, 2025
In today’s Pharmaceutical Executive Daily, we cover GSK’s supplemental application to update the label for Leucovorin, the FDA’s complete response le…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 22, 2025
In today’s Pharmaceutical Executive Daily, we cover Biogen’s acquisition of Alcyone Therapeutics to expand its drug delivery solutions, the FDA’s exp…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 19, 2025
In today’s Pharmaceutical Executive Daily, we cover how pharma companies can scale AI pilots into enterprise-wide value, GSK’s plan to invest $30 bil…
1 year, 1 month ago
Pharmaceutical Executive Daily: September 18, 2025
In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock Bio’s $50 million Series A f…
1 year, 2 months ago
Pharmaceutical Executive Daily: September 17, 2025
In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, Merck and Daiichi Sankyo’s…
1 year, 2 months ago